Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Trigyn Technologies Ltd (TRIGYN)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 517562 NSE: TRIGYN IT - Software | Small Cap | Trigyn Technologies Share Price
₹52.99 -3.48 (-6.16%)
As on 15-Sep'26 16:59
Trigyn Technologies Ltd (TRIGYN)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 517562 NSE: TRIGYN IT - Software | Small Cap | Trigyn Technologies Share Price
₹52.99 -3.48 (-6.16%)
As on 15-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹174 Cr.
Current Price
₹53
52-Week Low / High
₹37 / 101
TTM EPS
₹3.3
TTM Sales
₹1,005 Cr.
Book Value per Share
₹259.9
P/E Ratio
17.24
Lower than its 5-year historical median
Industry PE
20.8
Price to Book (P/B)
0.22
Lower than its 5-year historical median
Price to Sales (P/S)
0.17
Lower than its 5-year historical median
EV/EBITDA
-11.02
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
1.63%
Underperforms industry median
Return on Capital Employed (ROCE)
4.03%
Underperforms industry median
Return on Assets (ROA)
1.30%
Operating Profit Margin
2.2%
Net Profit Margin
1.31%
Gross Profit Margin
3.6%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-12.66%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-49.09%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-41.03%
Asset Quality
Promoter Holding
44.51%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹769 Cr.
Equity
₹30.8 Cr.
Face Value
₹10
All Time Low / High
₹5.80 / 3101.95
Check Before You Invest
Quality
Somewhat GoodValuation
UndervaluedCheck Valuation charts
Price Trend
Weak
Is Trigyn Technologies Ltd a good quality company?
Trigyn Technologies Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Trigyn Technologies Ltd performance compare with that of its Peers?
Revenue growth of Trigyn Technologies Ltd vs industry peers?
Trigyn Technologies Ltd revenue CAGR is -0.28%, compared to the industry median CAGR of 0%, indicating slower growth and losing its market share.
Promoter shareholding and pledge status of Trigyn Technologies Ltd?
Promoters hold 44.51% of the Trigyn Technologies Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Trigyn Technologies Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of -5.9% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Trigyn Technologies Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 2.1% | 1% | 0.7% | 8.1% | 6.8% | 4% | 2.9% | 4.5% | 5.3% | 4.7% | - |
| Value Creation Index ⓘ | -0.9 | -0.9 | -1.0 | -0.4 | -0.5 | -0.7 | -0.8 | -0.7 | -0.6 | -0.7 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 153 | 55.8 | 61.8 | 129 | 76.2 | 88.2 | 94.3 | 173 | 175 | 153 | 192 |
| Sales YoY Gr. | - | -63.5% | 10.8% | 108.4% | -40.8% | 15.7% | 6.8% | 83% | 1.6% | -12.7% | - |
| Adj EPS ⓘ | 0.6 | 0.6 | 0.2 | 2.3 | 1.9 | 1.1 | 0.3 | 1.9 | 2.4 | 1.2 | 2.7 |
| YoY Gr. | - | 16.4% | -76.6% | 1420% | -17.1% | -44.4% | -72.4% | 548.3% | 26.6% | -49.6% | - |
| BVPS (₹) ⓘ | 56.4 | 56.5 | 56.8 | 58.2 | 59.2 | 60.1 | 60.3 | 61.5 | 61.2 | 66 | 66.6 |
| Adj Net Profit ⓘ | 1.6 | 1.9 | 0.5 | 7 | 5.8 | 3.2 | 0.9 | 5.8 | 7.3 | 3.7 | 8 |
| Cash Flow from Ops. ⓘ | 4.4 | -1 | 1.6 | -10.3 | 2 | -3.8 | -9.9 | -5.5 | -5.8 | -6 | - |
| Debt/CF from Ops. ⓘ | 0 | -0.5 | 0.5 | -1.2 | 5.6 | -2.2 | -0.5 | -0.4 | -0 | -1.5 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 0% | 15% | 17.5% | -12.7% | ||||
| Adj EPS ⓘ | 9.1% | -8.7% | 60.5% | -49.6% | ||||
| BVPSⓘ | 1.8% | 2.2% | 3.1% | 7.9% | ||||
| Share Price | -6.1% | -15% | -25% | -27.6% | ||||
Key Financial Parameters ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 1 | 1.1 | 0.3 | 4 | 3.2 | 1.8 | 0.5 | 3.1 | 3.9 | 1.9 | 4 |
| Op. Profit Mgn % ⓘ | 1.6 | 3.2 | 2.8 | 10.1 | -2.5 | 3.5 | -9.3 | -6.7 | -8.7 | -0.7 | 4.9 |
| Net Profit Mgn % ⓘ | 1.1 | 3.4 | 0.8 | 5.4 | 7.6 | 3.7 | 0.9 | 3.4 | 4.2 | 2.4 | 4.3 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0.1 | 0.1 | 0.1 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 209 | 577 | 550 | 303 | 544 | 490 | 484 | 310 | 384 | 453 | 136 |
| Cash Conv. Cycle ⓘ | 104 | 240 | 159 | 63 | 224 | 259 | 228 | 113 | 108 | 141 | 45 |
Valuation of Trigyn Technologies - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 625 | 679 | 685 | 895 | 911 | 985 | 1,041 | 1,273 | 1,280 | 898 |
| Operating Expenses > ⓘ + | 563 | 614 | 624 | 810 | 833 | 893 | 975 | 1,212 | 1,245 | 880 |
| Operating Profit > ⓘ | 62 | 65 | 61 | 84 | 77 | 92 | 65 | 61 | 35 | 18 |
| Operating Profit Margin (%) | 9.9% | 9.6% | 8.9% | 9.4% | 8.5% | 9.4% | 6.3% | 4.8% | 2.7% | 2.0% |
| Other Income > ⓘ + | 3 | 3 | 1 | 1 | 5 | 3 | 3 | 6 | 12 | 18 |
| Interest > ⓘ | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 2 | 2 | 3 |
| Depreciation > ⓘ | 1 | 1 | 1 | 1 | 2 | 3 | 7 | 7 | 7 | 5 |
| Profit Before Tax > ⓘ | 62 | 66 | 60 | 78 | 78 | 89 | 59 | 58 | 38 | 26 |
| Tax > ⓘ | 24 | 27 | 20 | 30 | 28 | 27 | 20 | 24 | 18 | 15 |
| Profit After Tax | 38 | 39 | 39 | 48 | 50 | 62 | 39 | 35 | 20 | 12 |
| PAT Margin (%) | 6.1% | 5.8% | 5.8% | 5.4% | 5.5% | 6.3% | 3.8% | 2.7% | 1.6% | 1.3% |
| Adjusted EPS (₹) | 13.0 | 13.1 | 13.2 | 15.7 | 16.3 | 20.2 | 12.7 | 11.3 | 6.5 | 3.8 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 4.80% | 1.50% | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 288 | 324 | 366 | 433 | 503 | 558 | 607 | 681 | 701 | 741 | |
| Debt + | 0 | 0 | 0 | 8 | 6 | 8 | 5 | 2 | 0 | 9 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 33 | 37 | 53 | 65 | 72 | 77 | 84 | 98 | 80 | 70 | |
| Others Liabilities ⓘ | 35 | 33 | 36 | 39 | 43 | 52 | 71 | 87 | 100 | 105 | |
| Total Liabilities ⓘ | 355 | 395 | 455 | 545 | 624 | 695 | 768 | 868 | 881 | 925 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 88 | 89 | 90 | 90 | 100 | 99 | 108 | 107 | 103 | 97 | |
| CWIP ⓘ | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | |
| Investments ⓘ | 1 | 1 | 1 | 4 | 4 | 5 | 21 | 83 | 17 | 38 | |
| Inventories | 0 | 0 | 10 | 1 | 5 | 3 | 3 | 11 | 8 | 9 | |
| Trade Receivables | 143 | 127 | 138 | 194 | 259 | 241 | 282 | 305 | 249 | 244 | |
Cash Equivalents 
ⓘ
| 67 | 110 | 123 | 123 | 130 | 196 | 215 | 138 | 336 | 413 | |
| Others Assets ⓘ | 56 | 68 | 92 | 133 | 125 | 148 | 136 | 223 | 169 | 124 | |
| Total Assets ⓘ | 355 | 395 | 455 | 545 | 624 | 695 | 768 | 868 | 881 | 925 | |
| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 52 | 46 | 15 | -18 | -1 | 80 | 45 | -52 | 126 | 51 |
| Cash Flow From Investing Activity ⓘ + | 0 | 1 | -2 | -3 | -11 | -1 | -31 | -63 | 68 | 16 |
| Cash Flow From Financing Activity ⓘ + | -1 | -1 | -1 | 7 | -5 | -5 | -6 | -3 | -4 | -3 |
| Net Cash Flow ⓘ | 51 | 47 | 13 | -13 | -17 | 74 | 8 | -118 | 191 | 64 |
| PARTICULARS | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 14.34 | 12.75 | 11.44 | 12.13 | 10.7 | 11.72 | 6.71 | 5.38 | 2.89 | 1.63 |
| ROCE (%) | 23.55 | 21.78 | 17.36 | 19.47 | 16.65 | 16.96 | 10.45 | 9.34 | 5.76 | 4.03 |
| Asset Turnover Ratio | 1.91 | 1.81 | 1.61 | 1.79 | 1.56 | 1.49 | 1.42 | 1.56 | 1.46 | 0.99 |
| PAT to CFO Conversion(x) | 1.37 | 1.18 | 0.38 | -0.38 | -0.02 | 1.29 | 1.15 | -1.49 | 6.3 | 4.25 |
| Working Capital Days | ||||||||||
| Receivable Days | 86.70 | 72.50 | 70.70 | 67.70 | 90.80 | 92.80 | 91.70 | 84 | 79 | 100.10 |
| Inventory Days | 0 | 0 | 5.30 | 2.30 | 1.20 | 1.50 | 1.20 | 2 | 2.60 | 3.30 |
| Payable Days | 3,675 | 7,224.30 | 1,993.60 | 367.80 | 1,886 | 1,620.10 | 0 | 978.90 | 2,050.70 | 0 |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Trigyn Technologies Ltd FAQs
The current trading price of Trigyn Technologies on 15-Sep-2026 16:59 is ₹52.99.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 14-Sep-2026 the market cap of Trigyn Technologies stood at ₹173.8 Cr
The latest P/E ratio of Trigyn Technologies as of 14-Sep-2026 is 21.26.
The latest P/B ratio of Trigyn Technologies as of 14-Sep-2026 is 0.85.
The 52-week high of Trigyn Technologies is ₹101.3 and the 52-week low is ₹37.33.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Trigyn Technologies is ₹192 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Trigyn Technologies Ltd is a average quality company.
The key valuation ratios of Trigyn Technologies Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Trigyn Technologies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Trigyn Technologies Ltd
Trigyn Technologies Ltd was incorporated on March 25, 1986 in Maharashtra as a private limited company and was converted into a public limited company on August 8, 1994. It was promoted by software professionals, Ramkrishna Bhagwat Atul Kamath & Tushar Vaidya.
Trigyn Technologies is an innovative, software-led solutions provider and systems integrator. It has software professionals on board at locations in India, the US, Europe and the Far East - working round the clock to bring cutting-edge technology. They have development centers in New Jersey, Bangalore and Mumbai, India.
Innovative products, client-specific software services and solutions, highly complex system integration projects that enable and drive client-centric convergence in enterprises. That's what Trigyn Technologies offers.
Trigyn benefits from over 20 years of experience in the information technology industry and has an established client base of major fortune 500 companies in varying industry, World Governmental Organizations, and State Governments. Trigyn’s impressive client base portrays their ability to work with the best and to provide effective solutions using cutting edge technologies to meet and exceed expectations.
Products and services offered by the company:
Products:
- Apollo Apollo is a network independent billing application and works on the philosophy of 'Customer Empowerment'. The product is built entirely around the client, allowing the client to play a key role in planning his services & rate plans.
- Global Financial Trading Suite Trigyn Technologies has developed a comprehensive range of financial solutions which provide information systems with an array of analytical, risk-eliminating, controlling and decision-making tools.
- FundPro FundPro is a sophisticated package for Investment Management and Accounting catering to the needs of Mutual Funds and Insurance Companies.
Services:
Outsourcing ServicesRe-engineering & Migration Practice
QA Practice
Engineering PracticeStaff Augmentation Services
ECDM Services
- Documentum Practice
- Governance Practice
Achievements/ recognition:
- Trigyn has been awarded EMC Channel Partnership (July 04, 2008)
- Trigyn was Awarded Multi-Year Solutions Provider Contract by Massachusetts (July 01, 2008)
- Accreditation as “Microsoft Gold Certified Partner†by Microsoft Corporation (June 23, 2008)
- Trigyn was Awarded Multi-Million Dollar UN Managed Services Contract Extension (May 29, 2008)
- Trigyn was Awarded Microsoft Gold Certification (April 01, 2008)
- 2009 - Trigyn Wins State of Texas IT Staff Augmentation Services Contract
Trigyn Wins State of South Carolina IT Temporary Staffing Services Contract - 2010 Trigyn Wins 3 Commonwealth of Massachusetts Multi-Year Contracts
- 2011 - Trigyn Awarded Commonwealth of Massachusetts Solution Provider Contract2012
Trigyn Awarded New York City IT Services Contract Extension
Trigyn Awarded IT Staffing MSA by Fortune 500 Financial Services Company - 2013 - Trigyn Awarded Washington State Contracts
- 2014 - Trigyn Awarded Multi-Year California IT Consulting Services MSA
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
